Table of Contents
Editorials
| In this issue of Current Oncology | |
| Mike McLean | 1 |
Letter to the Editor
| In support of Canada’s health care system: an oncologist’s perspective | |
| A. Ali Zaidi | 2-3 |
Practice Guideline Series
| Sunitinib malate for gastrointestinal stromal tumour in imatinib mesylate–resistant patients: recommendations and evidence | |
| J. Younus, S. Verma, J. Franek, N. Coakley | 4-10 |
| Access to thalidomide for the treatment of multiple myeloma in Canada: physician behaviours and ethical implications | |
| L. Minuk, R. Sibbald, J. Peng, S. Bejaimal, I. Chin-Yee | 11-19 |
Medical Oncology
| Optimizing the management of HER2-positive early breast cancer: the clinical reality | |
| Su. Verma, S. Lavasani, J. Mackey, K. Pritchard, M. Clemons, S. Dent, J. Latreille, J. Lemieux, L. Provencher, Sh. Verma, S. Chia, B. Wang, D. Rayson | 20-33 |
| Adjuvant chemoradiation for gastric cancer with infusional 5-fluorouracil and cisplatin: a phase I study | |
| Z. Kassam, H. Mackay, C.A. Buckley, S. Fung, M. Pintile, A. Oza, J. Brierley, C. Swallow, B. Cummings, J.J. Knox, J. Kim, R. Wong, L. Siu, R. Feld, J. Ringash | 34-41 |
| Incidence of taxane-induced pain and distress in patients receiving chemotherapy for early-stage breast cancer: a retrospective, outcomes-based survey | |
| S. Saibil, B. Fitzgerald, O.C. Freedman, E. Amir, J. Napolskikh, N. Salvo, G. Dranitsaris, M. Clemons | 42-47 |
| Cetuximab in locally advanced head-and-neck cancer: defining the population | |
| C. Ho | 48-51 |
Biomarkers in Oncology
| The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer | |
| G. Kasymjanova, N. MacDonald, J.S. Agulnik, V. Cohen, C. Pepe, H. Kreisman, R. Sharma, D. Small | 52-58 |
Biomedical Ethics
| A case for tobacco content regulation by the U.S. Food and Drug Administration | |
| J.A. du Toit | 59-61 |
Cancer Rehabilitation and Survivorship
| Weathering storms: a cohort study of how participation in a mindfulness based stress reduction program benefits women after breast cancer treatment | |
| R.H. Matousek, P.L. Dobkin | 62-70 |
Pathology
| Dedifferentiated giant cell tumour of bone in the form of low-grade fibroblastic osteogenic sarcoma: case report of a unique presentation with follow-up | |
| A. Nahal, A. Ajlan, T. Alcindor, R. Turcotte | 71-76 |
Psychosocial Oncology
| Evaluating the impact on quality of life of chemoradiation in gastric cancer | |
| Z. Kassam, H. Mackay, C.A. Buckley, S. Fung, M. Pintilie, J. Kim, J. Ringash | 77-84 |
| Exploring cancer treatment decision-making by patients: a descriptive study | |
| D. Stacey, L. Paquet, R. Samant | 85-93 |
Radiation
| Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature | |
| N. Salvo, E. Barnes, J. van Draanen, E. Stacey, G. Mitera, D. Breen, A. Giotis, G. Czarnota, J. Pang, C. De Angelis | 94-112 |
Meeting Report
| BONUS 5: 5th Annual Bone and The Oncologist New Updates | |
| N. Bouganim, E. Amir, M. Clemons | 113-118 |
Case Report
| Radiation recall dermatitis with azithromycin | |
| O. Vujovic | 119-121 |
| Severe Raynaud syndrome induced by adjuvant interferon alfa in metastatic melanoma | |
| H. Husein-ElAhmed, J.L. Callejas-Rubio, R. Ortega Del Olmo, R. Rios-Fernandez, N. Ortego-Centeno | 122-123 |
| Aplastic anemia with concurrent temozolomide treatment in a patient with glioblastoma multiforme | |
| J. Oh, G.J. Kutas, P. Davey, M. Morrison, J.R. Perry | 124-126 |
| Malignant melanoma metastatic to the larynx: treatment and functional outcome | |
| B.G. Lanson, N. Sanfilippo, B. Wang, D. Grew, M.D. DeLacure | 127-132 |
| Ductal carcinoma in situ in a 25-year-old man presenting with apparent unilateral gynecomastia | |
| C.J. Coroneos, C. Hamm | 133-137 |
*Advertisement for Current Oncology
Copyright © 2010 by Multimed Inc.
Current Oncology. ISSN: 1198-0052